Aspen Aerogels (NYSE:ASPN) Given New $25.00 Price Target at HC Wainwright

Aspen Aerogels (NYSE:ASPN) had its price objective upped by HC Wainwright from $20.00 to $25.00 in a report published on Friday morning, Benzinga reports. They currently have a buy rating on the construction company’s stock.

Several other research firms have also commented on ASPN. Roth Mkm reaffirmed a buy rating and set a $22.00 target price on shares of Aspen Aerogels in a report on Tuesday. TheStreet upgraded shares of Aspen Aerogels from a d+ rating to a c- rating in a research report on Wednesday, March 6th. One investment analyst has rated the stock with a sell rating and six have issued a buy rating to the company. According to data from MarketBeat, Aspen Aerogels has an average rating of Moderate Buy and a consensus target price of $25.17.

Aspen Aerogels Stock Up 5.3 %

NYSE ASPN traded up $1.26 during trading hours on Friday, reaching $25.11. 3,351,897 shares of the company traded hands, compared to its average volume of 1,155,989. The company has a current ratio of 3.41, a quick ratio of 2.91 and a debt-to-equity ratio of 0.24. Aspen Aerogels has a 12 month low of $5.32 and a 12 month high of $25.65. The company has a 50 day moving average of $16.72 and a two-hundred day moving average of $13.69.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Tuesday, February 13th. The construction company reported ($0.01) EPS for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.11. Aspen Aerogels had a negative return on equity of 6.54% and a negative net margin of 10.73%. The company had revenue of $84.22 million for the quarter, compared to the consensus estimate of $83.82 million. During the same quarter last year, the business posted ($0.20) EPS. As a group, analysts expect that Aspen Aerogels will post 0.03 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. AIGH Capital Management LLC acquired a new position in Aspen Aerogels in the 3rd quarter worth about $15,067,000. Mesirow Institutional Investment Management Inc. acquired a new position in shares of Aspen Aerogels during the 4th quarter valued at about $12,015,000. Rice Hall James & Associates LLC boosted its position in Aspen Aerogels by 385.0% during the third quarter. Rice Hall James & Associates LLC now owns 623,135 shares of the construction company’s stock worth $5,359,000 after purchasing an additional 494,662 shares during the period. Worth Venture Partners LLC acquired a new position in Aspen Aerogels during the third quarter valued at approximately $3,684,000. Finally, Federated Hermes Inc. lifted its stake in shares of Aspen Aerogels by 53.9% in the fourth quarter. Federated Hermes Inc. now owns 1,154,042 shares of the construction company’s stock worth $18,211,000 after buying an additional 404,042 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.